Daily Stocks News » SNTS

Santarus to be Acquired by Salix Pharmaceuticals

Warren Paige — Sat, 09 Nov 2013 13:08:22 +0000

Shares of Santarus Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, surged in trading on Friday after the company agreed to be acquired by Salix Pharmaceuticals Ltd. (NASDAQ: SXLP). The two companies entered into a definitive agreement under which SLXP will acquire all outstanding shares of Santarus for $32 per share in cash. The offer price [...]

Major Movers on July 8; LINE, TRQ, SNTS, UNH, FB

Warren Paige — Mon, 08 Jul 2013 17:57:02 +0000

Shares of Linn Energy LLC (NASDAQ: LINE) rallied about 12% by mid-day trade. Bank of America Merrill Lynch upgraded the oil and gas firm’s rating to “buy” from “neutral”, citing company’s attractive valuation and said that cash flows are sustainable.

Just last week, company’s stock tumbled after it said that Securities and Exchange Commission [...]

Major Movers on May 7; FSLR, FOSL, MELI, RKUS, ARUN, SNTS, EOG, DTV

Warren Paige — Tue, 07 May 2013 18:11:46 +0000

Shares of First Solar Inc. (NASDAQ: FSLR) fell about 9.25% by afternoon trade. Although the solar panel maker, late last evening, reported that it swung into fiscal first quarter profit and handed revenue which edged past Street’s consensus estimate, investors were disappointed as adjusted earnings fell short of expectation. However, the Company maintained its full-year [...]

Santarus Shares Surge on FDA Approval of UCERIS (SNTS)

Warren Paige — Tue, 15 Jan 2013 21:10:28 +0000

Shares of Santarus Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company engaged in the acquisition, development and commercialization of products that address the needs of patients treated by physician specialists, surged on Tuesday after the company received FDA approval of UCERIS™ (budesonide) for the induction of remission in patients with active, mild to moderate ulcerative colitis.

[...]

Major Movers on January 15; LULU, DELL, AAPL, FRX, SNTS

Warren Paige — Tue, 15 Jan 2013 18:00:45 +0000

Shares of Lululemon Athletica Inc. (NASDAQ: LULU) slumped on Tuesday after the yoga and athletic apparel retailer late on Monday boosted its earnings projections for fiscal fourth quarter but remained in line with Street’s estimate and missed analysts’ revenue expectations.

The Vancouver-based company now expects EPS of 74 cents, up from its earlier guidance [...]